|
| 37916971 | Translational Aspects of Epithelioid Sarcoma: Current Consensus. | Clin Cancer Res | 2024 |
| 36915100 | Hypoxia and HIFs in Ewing sarcoma: new perspectives on a multi-facetted relationship. | Mol Cancer | 2023 |
| 37286428 | A century of retroperitoneal soft-tissue sarcoma research: From single center experience to precision oncology? A bibliometric analysis of past, present, and future perspectives. | Eur J Surg Oncol | 2023 |
| 36787739 | Targeted long-read sequencing of the Ewing sarcoma 6p25.1 susceptibility locus identifies germline-somatic interactions with EWSR1-FLI1 binding. | Am J Hum Genet | 2023 |
| 35228525 | Eukaryotic translation initiation factor 4E binding protein 1 (EIF4EBP1) expression in glioblastoma is driven by ETS1- and MYBL2-dependent transcriptional activation. | Cell Death Discov | 2022 |
| 35585241 | PHGDH heterogeneity potentiates cancer cell dissemination and metastasis. | Nature | 2022 |
| 35550257 | Oncogenic chimeric transcription factors drive tumor-specific transcription, processing, and translation of silent genomic regions. | Mol Cell | 2022 |
| 35839307 | Functional genomic analysis of epithelioid sarcoma reveals distinct proximal and distal subtype biology. | Clin Transl Med | 2022 |
| 35379801 | EIF4EBP1 is transcriptionally upregulated by MYCN and associates with poor prognosis in neuroblastoma. | Cell Death Discov | 2022 |
| 35459264 | Fusion protein-driven IGF-IR/PI3K/AKT signals deregulate Hippo pathway promoting oncogenic cooperation of YAP1 and FUS-DDIT3 in myxoid liposarcoma. | Oncogenesis | 2022 |
| 36149602 | ABCA6 affects the malignancy of Ewing sarcoma cells via cholesterol-guided inhibition of the IGF1R/AKT/MDM2 axis. | Cell Oncol (Dordr) | 2022 |
| 36070798 | Novel antigen-presenting cell imparts T<sub>reg</sub>-dependent tolerance to gut microbiota. | Nature | 2022 |
| 36042336 | Author Correction: PHGDH heterogeneity potentiates cancer cell dissemination and metastasis. | Nature | 2022 |
| 36202860 | Small round cell sarcomas. | Nat Rev Dis Primers | 2022 |
| 35955799 | Endoglin and MMP14 Contribute to Ewing Sarcoma Spreading by Modulation of Cell-Matrix Interactions. | Int J Mol Sci | 2022 |
| 36352194 | Correction to: ABCA6 affects the malignancy of Ewing sarcoma cells via cholesterol-guided inhibition of the IGF1R/AKT/MDM2 axis. | Cell Oncol (Dordr) | 2022 |
| 36115869 | An international working group consensus report for the prioritization of molecular biomarkers for Ewing sarcoma. | NPJ Precis Oncol | 2022 |
| 33908607 | MondoA drives malignancy in B-ALL through enhanced adaptation to metabolic stress. | Blood | 2022 |
| 34980141 | Integrative gene network and functional analyses identify a prognostically relevant key regulator of metastasis in Ewing sarcoma. | Mol Cancer | 2022 |
| 33479225 | Sarcoma classification by DNA methylation profiling. | Nat Commun | 2021 |
| 33767450 | Single-cell transcriptomic analyses provide insights into the developmental origins of neuroblastoma. | Nat Genet | 2021 |
| 33919988 | Ewing Sarcoma-Diagnosis, Treatment, Clinical Challenges and Future Perspectives. | J Clin Med | 2021 |
| 33687947 | Fat Induces Glucose Metabolism in Nontransformed Liver Cells and Promotes Liver Tumorigenesis. | Cancer Res | 2021 |
| 35121888 | Super enhancers define regulatory subtypes and cell identity in neuroblastoma. | Nat Cancer | 2021 |
| 34830820 | The Transcription Factor <i>FEZF1</i>, a Direct Target of <i>EWSR1-FLI1</i> in Ewing Sarcoma Cells, Regulates the Expression of Neural-Specific Genes. | Cancers (Basel) | 2021 |
| 34531368 | Therapeutic targeting of the PLK1-PRC1-axis triggers cell death in genomically silent childhood cancer. | Nat Commun | 2021 |
| 34341072 | Unraveling Ewing Sarcoma Tumorigenesis Originating from Patient-Derived Mesenchymal Stem Cells. | Cancer Res | 2021 |
| 34315482 | Translational evidence for RRM2 as a prognostic biomarker and therapeutic target in Ewing sarcoma. | Mol Cancer | 2021 |
| 33340488 | In Vivo Evidence for Serine Biosynthesis-Defined Sensitivity of Lung Metastasis, but Not of Primary Breast Tumors, to mTORC1 Inhibition. | Mol Cell | 2021 |
| 33326093 | (Immuno)histological Analysis of Ewing Sarcoma. | Methods Mol Biol | 2021 |
| 33326091 | Tissue Preservation and FFPE Samples: Optimized Nucleic Acids Isolation in Ewing Sarcoma. | Methods Mol Biol | 2021 |
| 33326089 | Germline Variation and Somatic Alterations in Ewing Sarcoma. | Methods Mol Biol | 2021 |
| 32222780 | A comparative view on the expression patterns of PD-L1 and PD-1 in soft tissue sarcomas. | Cancer Immunol Immunother | 2020 |
| 31732966 | Integrative clinical transcriptome analysis reveals TMPRSS2-ERG dependency of prognostic biomarkers in prostate adenocarcinoma. | Int J Cancer | 2020 |
| 32049009 | Transcriptional Programs Define Intratumoral Heterogeneity of Ewing Sarcoma at Single-Cell Resolution. | Cell Rep | 2020 |
| 31768620 | DNA methylation-based profiling of uterine neoplasms: a novel tool to improve gynecologic cancer diagnostics. | J Cancer Res Clin Oncol | 2020 |
| 31880317 | Hippo pathway effectors YAP1/TAZ induce an EWS-FLI1-opposing gene signature and associate with disease progression in Ewing sarcoma. | J Pathol | 2020 |
| 33051146 | Expression of the EWSR1-FLI1 fusion oncogene in pancreas cells drives pancreatic atrophy and lipomatosis. | Pancreatology | 2020 |
| 33047515 | Sarcoma treatment in the era of molecular medicine. | EMBO Mol Med | 2020 |
| 33230121 | Publisher Correction: Oncogenic hijacking of a developmental transcription factor evokes vulnerability toward oxidative stress in Ewing sarcoma. | Nat Commun | 2020 |
| 32579932 | mTOR Signaling and SREBP Activity Increase FADS2 Expression and Can Activate Sapienate Biosynthesis. | Cell Rep | 2020 |
| 32944640 | SOX6: a double-edged sword for Ewing sarcoma. | Mol Cell Oncol | 2020 |
| 32938628 | Leukemia escape in immune desert: intraocular relapse of pediatric pro-B-ALL during systemic control by CD19-CAR T cells. | J Immunother Cancer | 2020 |
| 32881892 | Low-frequency variation near common germline susceptibility loci are associated with risk of Ewing sarcoma. | PLoS One | 2020 |
| 32610710 | MHC Class I-Restricted TCR-Transgenic CD4<sup>+</sup> T Cells Against STEAP1 Mediate Local Tumor Control of Ewing Sarcoma In Vivo. | Cells | 2020 |
| 32415069 | Oncogenic hijacking of a developmental transcription factor evokes vulnerability toward oxidative stress in Ewing sarcoma. | Nat Commun | 2020 |
| 32235444 | Pan-Cancer Analysis of Mitochondria Chaperone-Client Co-Expression Reveals Chaperone Functional Partitioning. | Cancers (Basel) | 2020 |
| 32164354 | High Specificity of BCL11B and GLG1 for EWSR1-FLI1 and EWSR1-ERG Positive Ewing Sarcoma. | Cancers (Basel) | 2020 |
| 32483603 | Endogenous TCR promotes in vivo persistence of CD19-CAR-T cells compared to a CRISPR/Cas9-mediated TCR knockout CAR. | Blood | 2020 |
| 30267407 | Functional genomics identifies AMPD2 as a new prognostic marker for undifferentiated pleomorphic sarcoma. | Int J Cancer | 2019 |